Shai Yarkoni

1.7k total citations
63 papers, 1.4k citations indexed

About

Shai Yarkoni is a scholar working on Immunology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Shai Yarkoni has authored 63 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 11 papers in Molecular Biology and 10 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Shai Yarkoni's work include Immune Cell Function and Interaction (13 papers), T-cell and B-cell Immunology (7 papers) and Immunotherapy and Immune Responses (5 papers). Shai Yarkoni is often cited by papers focused on Immune Cell Function and Interaction (13 papers), T-cell and B-cell Immunology (7 papers) and Immunotherapy and Immune Responses (5 papers). Shai Yarkoni collaborates with scholars based in Israel, United States and France. Shai Yarkoni's co-authors include Nadir Askenasy, Ayelet Kaminitz, David S. Snyder, Arnon Nagler, Mark Pines, J C Hobbins, Liat Drucker, Haya Lorberboum‐Galski, Yuval Sagiv and E. Albert Reece and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Shai Yarkoni

62 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shai Yarkoni Israel 21 346 321 258 254 224 63 1.4k
Jacqueline Foidart Belgium 20 199 0.6× 164 0.5× 242 0.9× 109 0.4× 214 1.0× 37 1.6k
Sophie Collardeau‐Frachon France 21 389 1.1× 159 0.5× 369 1.4× 176 0.7× 174 0.8× 93 1.3k
Annikki Liakka Finland 16 376 1.1× 423 1.3× 101 0.4× 128 0.5× 249 1.1× 24 1.3k
Jules M. Elias United States 17 320 0.9× 268 0.8× 122 0.5× 139 0.5× 200 0.9× 62 1.3k
A.A. Verstraeten Netherlands 20 590 1.7× 402 1.3× 96 0.4× 202 0.8× 279 1.2× 31 1.3k
George Vartholomatos Greece 25 1.1k 3.2× 205 0.6× 244 0.9× 180 0.7× 306 1.4× 137 2.3k
Rinat Bernstein‐Molho Israel 25 594 1.7× 155 0.5× 146 0.6× 626 2.5× 218 1.0× 116 1.9k
Daniel Schimel United States 13 469 1.4× 138 0.4× 178 0.7× 267 1.1× 138 0.6× 18 1.4k
Norimichi Nemoto Japan 21 613 1.8× 218 0.7× 175 0.7× 211 0.8× 440 2.0× 105 1.7k
Sarah Guégan France 16 336 1.0× 206 0.6× 77 0.3× 111 0.4× 237 1.1× 43 1.0k

Countries citing papers authored by Shai Yarkoni

Since Specialization
Citations

This map shows the geographic impact of Shai Yarkoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shai Yarkoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shai Yarkoni more than expected).

Fields of papers citing papers by Shai Yarkoni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shai Yarkoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shai Yarkoni. The network helps show where Shai Yarkoni may publish in the future.

Co-authorship network of co-authors of Shai Yarkoni

This figure shows the co-authorship network connecting the top 25 collaborators of Shai Yarkoni. A scholar is included among the top collaborators of Shai Yarkoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shai Yarkoni. Shai Yarkoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Abraham, Michal, Inbal Mishalian, Tamar Katz, et al.. (2020). Brief ex vivo Fas-ligand incubation attenuates GvHD without compromising stem cell graft performance. Bone Marrow Transplantation. 55(7). 1305–1316. 2 indexed citations
3.
Yarkoni, Shai, Jerry Stein, Isaac Yaniv, & Nadir Askenasy. (2014). Antigen-Specific Priming is Dispensable in Depletion of Apoptosis-Sensitive T Cells for GvHD Prophylaxis. Frontiers in Immunology. 5. 215–215. 3 indexed citations
4.
Yarkoni, Shai, Tatyana B. Prigozhina, Shimon Slavin, & Nadir Askenasy. (2012). IL-2–Targeted Therapy Ameliorates the Severity of Graft-versus-Host Disease: Ex Vivo Selective Depletion of Host-Reactive T Cells and In Vivo Therapy. Biology of Blood and Marrow Transplantation. 18(4). 523–535. 12 indexed citations
5.
Yarkoni, Shai, Yuval Sagiv, Ayelet Kaminitz, Daniel L. Farkas, & Nadir Askenasy. (2009). Targeted therapy to the IL‐2R using diphtheria toxin and caspase‐3 fusion proteins modulates Treg and ameliorates inflammatory colitis. European Journal of Immunology. 39(10). 2850–2864. 9 indexed citations
6.
Sagiv, Yuval, et al.. (2009). A Fusion Protein Composed of IL‐2 and Caspase‐3 Ameliorates the Outcome of Experimental Inflammatory Colitis. Annals of the New York Academy of Sciences. 1173(1). 791–797. 6 indexed citations
7.
Yarkoni, Shai, Ayelet Kaminitz, Yuval Sagiv, & Nadir Askenasy. (2009). Targeting of IL-2 receptor with a caspase fusion protein disrupts autoimmunity in prediabetic and diabetic NOD mice. Diabetologia. 53(2). 356–368. 19 indexed citations
8.
Yolcu, Esma S., Shifra Ash, Ayelet Kaminitz, et al.. (2008). Apoptosis as a mechanism of T‐regulatory cell homeostasis and suppression. Immunology and Cell Biology. 86(8). 650–658. 61 indexed citations
9.
Xavier, Sandhya, Ester Piek, Makiko Fujii, et al.. (2004). Amelioration of Radiation-induced Fibrosis. Journal of Biological Chemistry. 279(15). 15167–15176. 170 indexed citations
10.
Drucker, Liat, et al.. (2000). Adenomatous polyposis coli I1307K mutation in Jewish patients with different ethnicity. Cancer. 88(4). 755–760. 24 indexed citations
11.
Drucker, Liat, et al.. (2000). Incidence of BRCA1 and BRCA2 mutations in Ashkenazi colorectal cancer patients: preliminary study.. PubMed. 20(1B). 559–61. 19 indexed citations
12.
Volk, Hans‐Dieter, S Müller, Shai Yarkoni, T Diamantstein, & Haya Lorberboum‐Galski. (1994). Mechanisms of dichotomous action of IL-2- Pseudomonas exotoxin 40 (IL-2-PE40) on cell-mediated and humoral immune response.. The Journal of Immunology. 153(6). 2497–2505. 10 indexed citations
13.
Altaras, Marco M., Rami Aviram, Ilan Cohen, et al.. (1993). Role of Prolonged Stimulation of Tamoxifen Therapy in the Etiology of Endometrial Sarcomas. Gynecologic Oncology. 49(2). 255–258. 45 indexed citations
14.
Schmidt, Wolfgang, Shai Yarkoni, P Jeanty, Peter Grannum, & J C Hobbins. (1985). Sonographic measurements of the fetal spleen: clinical implications.. Journal of Ultrasound in Medicine. 4(12). 667–672. 33 indexed citations
15.
Yarkoni, Shai, et al.. (1984). Treatment of IUD related menorrhagia by indomethacin.. PubMed. 11(4). 120–2. 4 indexed citations
16.
Sadovsky, E., et al.. (1984). The relationship between fetal heart rate accelerations, fetal movements, and uterine contractions. American Journal of Obstetrics and Gynecology. 149(2). 187–189. 20 indexed citations
17.
Yaffe, H, et al.. (1981). Establishment of a fetoscopy and fetal blood sampling program in Israel.. PubMed. 17(5). 352–4. 2 indexed citations
18.
Kohn, Gertrude, Shai Yarkoni, Maimon M. Cohen, & John M. Opitz. (1980). Two conceptions in a 45,X woman. American Journal of Medical Genetics. 5(4). 339–343. 21 indexed citations
19.
Yarkoni, Shai & Elena Sadovsky. (1978). Experience with the Ypsilon (Soichet) intrauterine device.. PubMed. 14(2). 267–70. 1 indexed citations
20.
Yarkoni, Shai, et al.. (1972). Follow-up of diabetic patients in pregnancy.. PubMed. 8(6). 790–790. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026